A pair of professional organizations in the U.K. is calling for the biopharma industry and national government to take action ...

VANCOUVER, BC / ACCESS Newswire / June 20, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that the Co-Founders of ...

Diversity in clinical trials can positively impact patient care and outcomes, particularly among minority populations, Anita ...

A policy win by the Foundation for Sarcoidosis Research has built momentum for other shifts that could bolster diversity in clinical trials.

The UK government has set out a 10 Year Health Plan, promising to transform clinical trials and make the UK a scientific ...

VANCOUVER, BC / ACCESS Newswire / June 20, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that the Co-Founders of ...

In our June issue, explore how clinical research is adapting to regulatory changes, AI advancements, and modernizing trial ...

Most large pharma companies have also ramped up public commitments to close clinical trial diversity gaps, says the report, including operational measures like inclusive early trial planning ...

Navigating a complex drug development landscape, sponsors must rethink their approach to risk in study design and execution.

The UK Government has announced its 10-Year Health Plan to expedite clinical trials and transform patient care with new ...

Judge William G. Young’s long career has been punctuated by high-profile cases and outspoken advocacy for the judiciary’s ...

As previously reported, 15 out of 16 (94%) patients in Phase 2b in the Per Protocol Population experienced Clinical Cure (CC) and all 15 of 15 (100%) remained free ...